AEHR Test Systems buy BiotechBee
Start price
03.09.23
/
70%
€48.70
Target price
30.09.25
€60.00
Performance (%)
-54.17%
End price
02.12.23
€22.32
Summary
This prediction ended on 02.12.23 with a price of €22.32. The BUY prediction by BiotechBee for AEHR Test Systems performed very badly with a performance of -54.17%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AEHR Test Systems | 3.569% | 3.569% | 43.016% |
| iShares Core DAX® | 0.765% | 4.791% | 21.634% |
| iShares Nasdaq 100 | 1.418% | 3.133% | 5.422% |
| iShares Nikkei 225® | 0.658% | 0.972% | 15.333% |
| iShares S&P 500 | 1.310% | 2.279% | 3.125% |
According to BiotechBee what are the pros and cons of AEHR Test Systems for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aehr Test Systems diskutieren
Buy mit Kursziel 60,0